Last $1.02 USD
Change Today 0.00 / 0.00%
Volume 40.6K
PURE On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

pure bioscience inc (PURE) Snapshot

Open
$1.01
Previous Close
$1.02
Day High
$1.03
Day Low
$0.95
52 Week High
10/22/13 - $1.70
52 Week Low
07/29/13 - $0.41
Market Cap
29.6M
Average Volume 10 Days
33.6K
EPS TTM
$-0.35
Shares Outstanding
29.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PURE BIOSCIENCE INC (PURE)

Related News

No related news articles were found.

pure bioscience inc (PURE) Related Businessweek News

No Related Businessweek News Found

pure bioscience inc (PURE) Details

PURE Bioscience, Inc. is engaged in developing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The company manufactures and distributes silver dihydrogen citrate based disinfecting and sanitizing products. Its technology platform is based on an electrochemical process that allows generating ionized silver in the presence of organic acid. The company’s products include PURE Hard Surface, a hard surface disinfectant and food contact surface sanitizer for use in food processing equipment, machinery, and utensils; PURE Multi-Purpose Cleaner, an environmentally cleaning product for use in various resilient surfaces, including floors, glass, and food contact surfaces; and Axen30, a hard surface disinfectant. Its products also comprise Axenohl, an antimicrobial formulation used as a raw material in the manufacturing of environmental protection agency-registered products; and Silvérion, an antimicrobial formulation used as a raw material in the manufacturing of personal care products. Pure Bioscience, Inc. markets and sells its products primarily to distributors and end users in the United States and internationally. The company was formerly known as PURE Bioscience and changed its name to Pure Bioscience, Inc. in March 2011. Pure Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

13 Employees
Last Reported Date: 10/24/13
Founded in 1992

pure bioscience inc (PURE) Top Compensated Officers

Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $143.8K
Compensation as of Fiscal Year 2013.

pure bioscience inc (PURE) Key Developments

PURE Bioscience Names Bridget Tinsley as Vice President Market Development

PURE Bioscience has appointed Bridget Tinsley to a newly-created position of Vice President Market Development. Tinsley will be responsible for both expanding the market for SDC as a food contact surface disinfectant and sanitizer and leading the future commercial applications of SDC as a food safety aid in the processing of poultry, meat and produce. Prior to joining PURE, Tinsley served as Senior Food Safety & Regulatory Specialist with Thermo Fisher Scientific. She previously served as the Manager of Global Food Programs for Underwriters Laboratories, where she was responsible for numerous global initiatives, including validation/verification services, and business development.

PURE Bioscience, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended April 30, 2014

PURE Bioscience, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended April 30, 2014. For the quarter, the company reported net product sales of $0.261 million compared to $0.258 million for the same period a year ago. Loss from operations was of $2.184 million compared to $1.577 million for the same period a year ago. Net loss was $2.049 million or $0.07 per basic and diluted share compared to $1.534 million or $0.14 per basic and diluted share for the same period a year ago. Net loss, as adjusted for significant items was $1.279 million compared to $1.381 million for the same period a year ago. For nine months, the company reported net product sales of $0.417 million compared to $0.631 million for the same period a year ago. Loss from operations was of $9.237 million compared to $5.179 million for the same period a year ago. Net loss was $8.375 million or $0.34 per basic and diluted share compared to $5.512 million or $0.53 per basic and diluted share for the same period a year ago. Net loss, as adjusted for significant items was $3.849 million compared to $4.929 million for the same period a year ago.

PURE Bioscience, Inc., Q3 2014 Earnings Call, Jun 10, 2014

PURE Bioscience, Inc., Q3 2014 Earnings Call, Jun 10, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PURE:US $1.02 USD 0.00

PURE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PURE.
View Industry Companies
 

Industry Analysis

PURE

Industry Average

Valuation PURE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 46.9x
Price/Book 22.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 48.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PURE BIOSCIENCE INC, please visit www.purebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.